The growing interest in biotechnology development and the high demand for biopharmaceuticals have contributed to the growth of the global biopharmaceutical market, which now comprises over 200 ...

Despite the importance of downstream bioprocessing, there are many opportunities for improvement, according to a report by Alois Jungbauer, PhD, a retired professor of biotechnology at the University ...

DSM has added Kremer Method™, an innovative proprietary technology to improve downstream processing of monoclonal antibodies for faster and more cost effective production of biopharmaceuticals. The ...

Marcus Curl leads the product applications team working with leading developers in cell and gene therapy and vaccines to help them improve their workflows by implementing recombinant, scalable and ...

The growing interest in biotechnology development and the high demand for biopharmaceuticals have contributed to the growth of the global biopharmaceutical market, which now comprises over 200 ...